These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 16436310)

  • 41. Defining elements of success: a critical pathway of coalition development.
    Downey LM; Ireson CL; Slavova S; McKee G
    Health Promot Pract; 2008 Apr; 9(2):130-9. PubMed ID: 18340088
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chronic disease prevention and the politics of scale: lessons from Canadian health reform.
    Masuda JR; Robinson K; Elliott SJ; Eyles J
    Soc Work Public Health; 2012; 27(7):639-57. PubMed ID: 23145549
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Why did some Danish counties introduce breast cancer screening and others not? An exploratory study of four selected counties.
    Hjulmann K; Vondeling H; Bech M
    Int J Technol Assess Health Care; 2008; 24(3):326-32. PubMed ID: 18601801
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Understanding the Dynamics of More Restrictive Medicines Policy: A Case Study of Codeine Up-Scheduling in Australia.
    Chiu K; Thow AM; Bero L
    Int J Health Policy Manag; 2023; 12():6872. PubMed ID: 37579455
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A conceptual framework for interprofessional and co-managed care.
    Retchin SM
    Acad Med; 2008 Oct; 83(10):929-33. PubMed ID: 18820522
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Introducing out-of-pocket payment for general practice in Denmark: feasibility and support.
    Poulsen CA
    Health Policy; 2014 Jul; 117(1):64-71. PubMed ID: 24836020
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The emerging mental health strategy of the European Union: a multi-level work-in-progress.
    Kelly BD
    Health Policy; 2008 Jan; 85(1):60-70. PubMed ID: 17643547
    [TBL] [Abstract][Full Text] [Related]  

  • 48. How should cost-effectiveness analysis be used in health technology coverage decisions? Evidence from the National Institute for Health and Clinical Excellence approach.
    Williams I; Bryan S; McIver S
    J Health Serv Res Policy; 2007 Apr; 12(2):73-9. PubMed ID: 17407655
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Utilization of epidemiological research for the development of local public health policy in The Netherlands: a case study approach.
    de Goede J; Putters K; van Oers H
    Soc Sci Med; 2012 Mar; 74(5):707-14. PubMed ID: 22265086
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Utility of qualitative research findings in evidence-based public health practice.
    Jack SM
    Public Health Nurs; 2006; 23(3):277-83. PubMed ID: 16684207
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Autonomous public organization policy: a case study for the health sector in Thailand.
    Rajataramya B; Fried B; van der Pütten M; Pongpanich S
    Southeast Asian J Trop Med Public Health; 2009 Sep; 40(5):1092-102. PubMed ID: 19842394
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Patient empowerment and the introduction of hospital choice in Denmark and Norway.
    Vrangbaek K; Ostergren K
    Health Econ Policy Law; 2006 Oct; 1(Pt 4):371-94. PubMed ID: 18634678
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The impact of context on evidence utilization: a framework for expert groups developing health policy recommendations.
    Dobrow MJ; Goel V; Lemieux-Charles L; Black NA
    Soc Sci Med; 2006 Oct; 63(7):1811-24. PubMed ID: 16764980
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Conditional reimbursement within the Dutch drug policy.
    Niezen M; de Bont A; Stolk E; Eyck A; Niessen L; Stoevelaar H
    Health Policy; 2007 Nov; 84(1):39-50. PubMed ID: 17207886
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Notes from the laboratories of democracy: state government enactments of market- and state-based health insurance reforms in the 1990s.
    Barrilleaux C; Brace P
    J Health Polit Policy Law; 2007 Aug; 32(4):655-83. PubMed ID: 17639016
    [TBL] [Abstract][Full Text] [Related]  

  • 56. What coalition factors foster community capacity? Lessons learned from the Fighting Back Initiative.
    Zakocs RC; Guckenburg S
    Health Educ Behav; 2007 Apr; 34(2):354-75. PubMed ID: 16861592
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Examining the Washington State Breastfeeding-Friendly Policy Development Process Using the Advocacy Coalition Framework.
    Steinman LE; Bradford V; Quinn E; Otten JJ; McNamara J; Fisher K; Johnson DB
    Matern Child Health J; 2017 Mar; 21(3):659-669. PubMed ID: 27497602
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The changing process and politics of health policy in Korea.
    Kwon S; Reich MR
    J Health Polit Policy Law; 2005 Dec; 30(6):1003-26. PubMed ID: 16481306
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mechanism of cross-sectoral coordination between nature protection and forestry in the Natura 2000 formulation process in Slovakia.
    Sarvašová Z; Sálka J; Dobšinská Z
    J Environ Manage; 2013 Sep; 127 Suppl():S65-72. PubMed ID: 22771263
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influencing policy development: the whirling dervish of the autism in-home program.
    Muckian J
    J Pediatr Nurs; 2007 Jun; 22(3):223-30. PubMed ID: 17524966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.